Your browser doesn't support javascript.
loading
Intrinsic suppression of type I interferon production underlies the therapeutic efficacy of IL-15-producing natural killer cells in B-cell acute lymphoblastic leukemia.
Kumar, Anil; Taghi Khani, Adeleh; Duault, Caroline; Aramburo, Soraya; Sanchez Ortiz, Ashly; Lee, Sung June; Chan, Anthony; McDonald, Tinisha; Huang, Min; Lacayo, Norman J; Sakamoto, Kathleen M; Yu, Jianhua; Hurtz, Christian; Carroll, Martin; Tasian, Sarah K; Ghoda, Lucy; Marcucci, Guido; Gu, Zhaohui; Rosen, Steven T; Armenian, Saro; Izraeli, Shai; Chen, Chun-Wei; Caligiuri, Michael A; Forman, Stephen J; Maecker, Holden T; Swaminathan, Srividya.
Afiliación
  • Kumar A; Department of Systems Biology, City of Hope Beckman Research Institute, Monrovia, California, USA.
  • Taghi Khani A; Department of Systems Biology, City of Hope Beckman Research Institute, Monrovia, California, USA.
  • Duault C; The Human Immune Monitoring Center (HIMC), Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, California, USA.
  • Aramburo S; Department of Systems Biology, City of Hope Beckman Research Institute, Monrovia, California, USA.
  • Sanchez Ortiz A; Department of Systems Biology, City of Hope Beckman Research Institute, Monrovia, California, USA.
  • Lee SJ; Department of Systems Biology, City of Hope Beckman Research Institute, Monrovia, California, USA.
  • Chan A; Department of Systems Biology, City of Hope Beckman Research Institute, Monrovia, California, USA.
  • McDonald T; The Hematopoietic Tissue Biorepository/Research Pathology Shared Resources, City of Hope, Duarte, California, USA.
  • Huang M; Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA.
  • Lacayo NJ; Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA.
  • Sakamoto KM; Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA.
  • Yu J; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California, USA.
  • Hurtz C; Department of Cancer and Cellular Biology, Fels Cancer Institute for Personalized Medicine Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania, USA.
  • Carroll M; Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Tasian SK; Department of Pediatrics, Division of Oncology, The Children's Hospital, Philadelphia, Pennsylvania, USA.
  • Ghoda L; Hematological Malignancies Translational Science, City of Hope, Duarte, California, USA.
  • Marcucci G; The Hematopoietic Tissue Biorepository/Research Pathology Shared Resources, City of Hope, Duarte, California, USA.
  • Gu Z; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California, USA.
  • Rosen ST; Hematological Malignancies Translational Science, City of Hope, Duarte, California, USA.
  • Armenian S; Department of Systems Biology, City of Hope Beckman Research Institute, Monrovia, California, USA.
  • Izraeli S; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California, USA.
  • Chen CW; Department of Pediatrics, City of Hope, Duarte, California, USA.
  • Caligiuri MA; Department of Systems Biology, City of Hope Beckman Research Institute, Monrovia, California, USA.
  • Forman SJ; Hematology-Oncology Department, Tel Aviv University, Tel Aviv, Israel.
  • Maecker HT; Department of Systems Biology, City of Hope Beckman Research Institute, Monrovia, California, USA.
  • Swaminathan S; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California, USA.
J Immunother Cancer ; 11(5)2023 05.
Article en En | MEDLINE | ID: mdl-37217248
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Interferón Tipo I / Linfoma de Burkitt / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: J Immunother Cancer Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Interferón Tipo I / Linfoma de Burkitt / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: J Immunother Cancer Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos